Ireland, R., Davies, C., Keyser, E., Findlay, J., Eastaugh, L., Laws, T., … Nelson, M. (2022). Histopathological and Immunological Findings in the Common Marmoset Following Exposure to Aerosolized SARS-CoV-2. Viruses, 14(7). https://doi.org/10.3390/v14071580 (Original work published 2022)
SARS-CoV-2
Ye, C., Park, J.-G., Chiem, K., Dravid, P., Allué-Guardia, A., Garcia-Vilanova, A., … Martinez-Sobrido, L. (2023). Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral Transmission. Microbiology Spectrum, 11(3), e0065323. https://doi.org/10.1128/spectrum.00653-23 (Original work published 2023)
Wen, Z., Yuan, Y., Zhao, Y., Wang, H., Han, Z., Li, M., … Sun, C. (2023). Enhancement of SARS-CoV-2 N Antigen-Specific T Cell Functionality by Modulating the Autophagy-Mediated Signal Pathway in Mice. Viruses, 15(6). https://doi.org/10.3390/v15061316 (Original work published 2023)
Yu, J., Thomas, P. , V, Sciacca, M., Wu, C., Liu, J., He, X., … Barouch, D. (2023). Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaques. Cell Reports. Medicine, 4(4), 101018. https://doi.org/10.1016/j.xcrm.2023.101018 (Original work published 2023)
He, T., Ling, N., Zhang, G., Xiang, D., Hu, P., Peng, M., … Ren, H. (2023). Decreased antibody response to influenza vaccine with an enhanced antibody response to subsequent SARS-CoV-2 vaccination in patients with chronic hepatitis B virus infection. Immunity, Inflammation and Disease, 11(1), e759. https://doi.org/10.1002/iid3.759 (Original work published 2023)
Wen, Z., Fang, C., Liu, X., Liu, Y., Li, M., Yuan, Y., … Sun, C. (2023). A recombinant Mycobacterium smegmatis-based surface display system for developing the T cell-based COVID-19 vaccine. Human Vaccines & Immunotherapeutics, 19(1), 2171233. https://doi.org/10.1080/21645515.2023.2171233 (Original work published 2023)
Tedjakusuma, S., Lester, C., Neuhaus, E., Dora, E., Gutierrez, S., Braun, M., … Flitter, B. (2024). A Next-Generation Adenoviral Vaccine Elicits Mucosal and Systemic Immunogenicity and Reduces Viral Shedding after SARS-CoV-2 Challenge in Nonhuman Primates. Vaccines, 12(2). https://doi.org/10.3390/vaccines12020132 (Original work published 2024)
Liu, J., Han, H., Yang, B., Zhang, N., Li, J., Chen, X., … Yang, Y. (2024). Immunogenicity and protective efficacy of the HC009 mRNA vaccine against SARS-CoV-2. Frontiers in Immunology, 15, 1416375. https://doi.org/10.3389/fimmu.2024.1416375 (Original work published 2024)
Atanasova, M., Dimitrov, I., Ralchev, N., Markovski, A., Manoylov, I., Bradyanova, S., … Doytchinova, I. (2024). Design, Development and Immunogenicity Study of a Multi-Epitope Vaccine Prototype Against SARS-CoV-2. Pharmaceuticals (Basel, Switzerland), 17(11). https://doi.org/10.3390/ph17111498 (Original work published 2024)
Wang, C., Tang, X., Jiang, C., Zhang, Y., Han, B., Sun, Y., … Jiang, C. (2025). Intradermal delivery of SARS-CoV-2 RBD3-Fc mRNA vaccines via a needle-free injection system induces robust immune responses in rats. Frontiers in Immunology, 16, 1530736. https://doi.org/10.3389/fimmu.2025.1530736 (Original work published 2025)